| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |